The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome
- PMID: 2043940
- DOI: 10.1093/brain/114.2.1045
The natural history of multiple sclerosis: a geographically based study. 3. Multivariate analysis of predictive factors and models of outcome
Abstract
A multivariate hierarchical analysis was used to assess the significance of several demographic and clinical factors in multiple sclerosis patients. We used the time to reach level 6 on the disability status scale (DSS) of Kurtzke as endpoint. Several factors at presentation were significantly associated with an adverse outcome including older age at onset, male sex, cerebellar involvement or insidious onset of a motor deficit as first symptom. Factors ascertained later which were associated significantly with a worse outcome, even after controlling for those previously mentioned, included persisting deficits in brainstem, cerebellar or cerebral systems, a higher frequency of attacks in the first 2 yrs after onset of disease, a short first interattack interval and higher DSS at 2 yrs and 5 yrs from onset. An analysis similar to multiple regression was used to generate predictive models which permit the calculation of the median time to DSS 6 for patients with a given set of covariates. The goodness of fit of these models to the data and their predictive accuracy are discussed.
Similar articles
-
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis.Brain. 1999 Apr;122 ( Pt 4):625-39. doi: 10.1093/brain/122.4.625. Brain. 1999. PMID: 10219776
-
The natural history of multiple sclerosis: a geographically based study. 4. Applications to planning and interpretation of clinical therapeutic trials.Brain. 1991 Apr;114 ( Pt 2):1057-67. doi: 10.1093/brain/114.2.1057. Brain. 1991. PMID: 2043941
-
Age at disability milestones in multiple sclerosis.Brain. 2006 Mar;129(Pt 3):595-605. doi: 10.1093/brain/awh714. Epub 2006 Jan 16. Brain. 2006. PMID: 16415309
-
Prognosis of multiple sclerosis: clinical factors predicting the late evolution for an early treatment decision.Expert Rev Neurother. 2006 Mar;6(3):357-64. doi: 10.1586/14737175.6.3.357. Expert Rev Neurother. 2006. PMID: 16533140 Review.
-
Prognostic factors for multiple sclerosis: the importance of natural history studies.J Neurol. 2005 Sep;252 Suppl 3:iii15-iii20. doi: 10.1007/s00415-005-2012-4. J Neurol. 2005. PMID: 16170495 Review.
Cited by
-
Turning and multitask gait unmask gait disturbance in mild-to-moderate multiple sclerosis: Underlying specific cortical thinning and connecting fibers damage.Hum Brain Mapp. 2023 Feb 15;44(3):1193-1208. doi: 10.1002/hbm.26151. Epub 2022 Nov 21. Hum Brain Mapp. 2023. PMID: 36409700 Free PMC article.
-
Advances in the management of relapsing-remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12).Degener Neurol Neuromuscul Dis. 2015 May 21;5:51-61. doi: 10.2147/DNND.S68723. eCollection 2015. Degener Neurol Neuromuscul Dis. 2015. PMID: 32669912 Free PMC article. Review.
-
European validation of a standardized clinical description of multiple sclerosis.J Neurol. 2004 Dec;251(12):1472-80. doi: 10.1007/s00415-004-0567-0. J Neurol. 2004. PMID: 15645346
-
Vascular comorbidity is associated with more rapid disability progression in multiple sclerosis.Neurology. 2010 Mar 30;74(13):1041-7. doi: 10.1212/WNL.0b013e3181d6b125. Neurology. 2010. PMID: 20350978 Free PMC article.
-
A five-year observational prospective mono-center study of the efficacy of alemtuzumab in a real-world cohort of patients with multiple sclerosis.Front Neurol. 2023 Sep 21;14:1265354. doi: 10.3389/fneur.2023.1265354. eCollection 2023. Front Neurol. 2023. PMID: 37808497 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical